Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Efficacy and Safety of Switching to Dolutegravir/Lamivudine in Virologically Suppressed HIV-1 Infected Adults with TDF-Related Renal or Bone Toxicity

Saved in:
Bibliographic Details
Published in:Infectious Diseases and Therapy
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1868553644676218880
collection WordPress RSS
FRELIP Feed Integration
container_title Infectious Diseases and Therapy
description
discipline_display Communicable Diseases, Epidemiology
discipline_facet Communicable Diseases, Epidemiology
format Online Article
RSS Article
genre Journal Article
id rss_article:79367
institution FRELIP
journal_source_facet Infectious Diseases and Therapy
last_indexed 2026-06-20T21:40:16.351Z
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle Efficacy and Safety of Switching to Dolutegravir/Lamivudine in Virologically Suppressed HIV-1 Infected Adults with TDF-Related Renal or Bone Toxicity
Communicable Diseases, Epidemiology
General
Communicable Diseases, Epidemiology
sub_discipline_display General
sub_discipline_facet General
subject_display Communicable Diseases, Epidemiology
General
Communicable Diseases, Epidemiology
subject_facet Communicable Diseases, Epidemiology
General
Communicable Diseases, Epidemiology
title Efficacy and Safety of Switching to Dolutegravir/Lamivudine in Virologically Suppressed HIV-1 Infected Adults with TDF-Related Renal or Bone Toxicity
title_alt Eficacia y seguridad del cambio a dolutegravir/lamivudina en adultos infectados por VIH-1 con supresión virológica y toxicidad renal u ósea relacionada con TDF
Efficacité et sécurité du passage au dolutégravir/lamivudine chez les adultes infectés par le VIH-1 avec suppression virologique et toxicité rénale ou osseuse liée au TDF
Eficácia e Segurança da Mudança para Dolutegravir/Lamivudina em Adultos Infectados pelo HIV-1 Suprimidos Virologicamente com Toxicidade Renal ou Óssea Relacionada ao TDF
title_auth Efficacy and Safety of Switching to Dolutegravir/Lamivudine in Virologically Suppressed HIV-1 Infected Adults with TDF-Related Renal or Bone Toxicity
title_es_txt Eficacia y seguridad del cambio a dolutegravir/lamivudina en adultos infectados por VIH-1 con supresión virológica y toxicidad renal u ósea relacionada con TDF
title_fr_txt Efficacité et sécurité du passage au dolutégravir/lamivudine chez les adultes infectés par le VIH-1 avec suppression virologique et toxicité rénale ou osseuse liée au TDF
title_full Efficacy and Safety of Switching to Dolutegravir/Lamivudine in Virologically Suppressed HIV-1 Infected Adults with TDF-Related Renal or Bone Toxicity
title_fullStr Efficacy and Safety of Switching to Dolutegravir/Lamivudine in Virologically Suppressed HIV-1 Infected Adults with TDF-Related Renal or Bone Toxicity
title_full_unstemmed Efficacy and Safety of Switching to Dolutegravir/Lamivudine in Virologically Suppressed HIV-1 Infected Adults with TDF-Related Renal or Bone Toxicity
title_pt_txt Eficácia e Segurança da Mudança para Dolutegravir/Lamivudina em Adultos Infectados pelo HIV-1 Suprimidos Virologicamente com Toxicidade Renal ou Óssea Relacionada ao TDF
title_short Efficacy and Safety of Switching to Dolutegravir/Lamivudine in Virologically Suppressed HIV-1 Infected Adults with TDF-Related Renal or Bone Toxicity
title_sort efficacy and safety of switching to dolutegravir/lamivudine in virologically suppressed hiv-1 infected adults with tdf-related renal or bone toxicity
topic Communicable Diseases, Epidemiology
General
Communicable Diseases, Epidemiology
url https://link.springer.com/article/10.1007/s40121-026-01363-y